<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8100316</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1138</journal-id>
<journal-id journal-id-type="nlm-ta">Biomaterials</journal-id>
<journal-id journal-id-type="iso-abbrev">Biomaterials</journal-id>
<journal-title-group>
<journal-title>Biomaterials</journal-title>
</journal-title-group>
<issn pub-type="ppub">0142-9612</issn>
<issn pub-type="epub">1878-5905</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30391800</article-id>
<article-id pub-id-type="pmc">6289621</article-id>
<article-id pub-id-type="doi">10.1016/j.biomaterials.2018.10.023</article-id>
<article-id pub-id-type="manuscript">NIHMS1511543</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Human iPSC-derived blood-brain barrier microvessels: validation of barrier function and endothelial cell behavior</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Linville</surname>
<given-names>Raleigh M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>DeStefano</surname>
<given-names>Jackson G.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sklar</surname>
<given-names>Matt B.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Zinnia</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Farrell</surname>
<given-names>Alanna M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bogorad</surname>
<given-names>Max I.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chu</surname>
<given-names>Chengyan</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Walczak</surname>
<given-names>Piotr</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cheng</surname>
<given-names>Linzhao</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mahairaki</surname>
<given-names>Vasiliki</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Whartenby</surname>
<given-names>Katharine A.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Calabresi</surname>
<given-names>Peter A.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Searson</surname>
<given-names>Peter C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Institute for Nanobiotechnology, Johns Hopkins University, Baltimore, MD</aff>
<aff id="A2"><label>2</label>Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD</aff>
<aff id="A3"><label>3</label>Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD</aff>
<aff id="A4"><label>4</label>Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD</aff>
<aff id="A5"><label>5</label>Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD</aff>
<aff id="A6"><label>6</label>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD</aff>
<author-notes>
<fn fn-type="other" id="FN1">
<p id="P1">RML, JGD and PCS conceived the study and wrote the paper. RML, JGD, MBS, ZX, and AMF conducted experiments. RML and MIB analyzed barrier function data. JGD, MBS and AMF analyzed endothelial cell data. CC and PW assisted in designing, conducting and analyzing mannitol experiments. LC, VM, KAW, and PAC provided human iPSC lines and data. All authors reviewed and accepted the manuscript.</p>
</fn>
<corresp id="CR1"><label>*</label>corresponding author: Peter C. Searson, PhD, 100 Croft Hall, Johns Hopkins University, 3400 North Charles Street, Baltimore, MD 21218, <email>searson@jhu.edu</email>, 410 516 8774, fax: 410 516 2355</corresp>
<corresp id="CR2">Author contributions</corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P58">Conflict of interest</p>
<p id="P59">The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>14</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2020</year>
</pub-date>
<volume>190-191</volume>
<fpage>24</fpage>
<lpage>37</lpage>
<!--elocation-id from pubmed: 10.1016/j.biomaterials.2018.10.023-->
<abstract id="ABS1">
<p id="P2">Microvessels of the blood-brain barrier (BBB) regulate transport into the brain. The highly specialized brain microvascular endothelial cells, a major component of the BBB, express tight junctions and efflux transporters which regulate paracellular and transcellular permeability. However, most existing models of BBB microvessels fail to exhibit physiological barrier function. Here, using (iPSC)-derived human brain microvascular endothelial cells (dhBMECs) within templated type I collagen channels we mimic the cylindrical geometry, cell-extracellular matrix interactions, and shear flow typical of human brain post-capillary venules. We characterize the structure and barrier function in comparison to non-brain-specific microvessels, and show that dhBMEC microvessels recapitulate physiologically low solute permeability and quiescent endothelial cell behavior. Transcellular permeability is increased two-fold using a clinically relevant dose of a p-glycoprotein inhibitor tariquidar, while paracellular permeability is increased using a bolus dose of hyperosmolar agent mannitol. Lastly, we show that our human BBB microvessels are responsive to inflammatory cytokines via upregulation of surface adhesion molecules and increased leukocyte adhesion, but no changes in permeability. Human iPSC-derived blood-brain barrier microvessels support quantitative analysis of barrier function and endothelial cell dynamics in quiescence and in response to biologically- and clinicallyrelevant perturbations.</p>
</abstract>
<kwd-group>
<kwd>blood-brain barrier</kwd>
<kwd>permeability</kwd>
<kwd>microvessels</kwd>
<kwd>induced pluripotent stem cells</kwd>
<kwd>brain microvascular endothelial cells</kwd>
<kwd>tissue engineering</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>